Jose Fernando Moura, PhD· @FernandoOnco · X·· 14 小时前评分70
正文 · 原文
SANOVO - New strategy to overcome MET resistance in mEGFR NSCLC
Savolitinib + Osi
Side effects are the concern
Strong signal in survival
@myESMO #ESMO26 @OncoAlert @HHorinouchi
20 浏览 · 0 赞 · 0 转发 · 0 回复
来源：Jose Fernando Moura, PhD · x.com